Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
06/2000
06/29/2000WO2000037503A1 Compositions and methods for generating monoclonal antibodies representative of a specific cell type
06/29/2000WO2000037502A2 Vascular endothelial cell growth factor antagonists and uses thereof
06/29/2000WO2000037496A1 Novel fibronectin-binding protein
06/29/2000WO2000037494A2 Chlamydia trachomatis antigens
06/29/2000WO2000037493A2 Type iii secretion system antigens from bordetella pertussis
06/29/2000WO2000037490A2 Outer surface proteins, their genes, and their use
06/29/2000WO2000037107A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia
06/29/2000WO2000037106A1 Oral vaccine against diarrhea
06/29/2000WO2000037105A2 Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
06/29/2000WO2000037104A1 Improved recombinant hepatitis b surface antigen
06/29/2000WO2000037102A2 Improvement of tolerance to a xenograft
06/29/2000WO2000037101A1 Method to produce inactivated w/o emulsion adjuvated vaccines
06/29/2000WO2000037100A2 Compositions and methods for reducing or preventing fertilization in fish and birds
06/29/2000WO2000037085A1 Treatment of diseases involving cyst formation
06/29/2000WO2000037067A2 Sensitizing agents for the treatment of skin lesions
06/29/2000WO2000037053A1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles
06/29/2000WO2000037052A1 Pulmonary drug delivery
06/29/2000WO2000037051A1 Aerosol formulations for buccal and pulmonary application
06/29/2000WO2000037025A2 Antibodies to truncated vegf-d and uses thereof
06/29/2000WO2000012677A3 Generation of recombinant infectious bursal disease viruses by reverse genetics technology and the use of the recombinant viruses as attenuated vaccines
06/29/2000WO2000012497A3 Quinazoline derivatives as medicaments
06/29/2000WO2000012129A3 Salmonella typhi vaccine compositions
06/29/2000WO2000012113A3 Method of modulating memory effector t-cells using a cd2-binding agent, and compositions
06/29/2000WO2000009073A3 Blood-brain barrier therapeutics
06/29/2000WO2000006737A3 Streptococcus pneumoniae proteins and nucleic acid molecules
06/29/2000WO2000001409A3 Porcine circovirus and parvovirus vaccine
06/29/2000WO2000000610A3 Human signal peptide-containing proteins
06/29/2000WO2000000594A3 Human transferases
06/29/2000WO1998059034A3 Treponema pallidum polynucleotides and sequences
06/29/2000WO1998050067A3 Use or a secretion vector for fertility control by oral vaccination
06/29/2000DE19954305A1 Peptide des AT¶1¶-Rezeptors und ihre Verwendung, insbesondere für die Diagnostider Präeklampsie Peptides of AT¶1¶ receptor and their use, in particular for pre-eclampsia Diagnostider
06/29/2000DE19860132A1 Use of allergens or allergenic vaccines in the treatment of allergies
06/29/2000CA2450402A1 Methods and compositions for inhibiting cancer cell growth comprising pro224
06/29/2000CA2371289A1 Novel polypeptides and nucleic acids encoding same
06/29/2000CA2359586A1 Orally immunogenic bacterial enterotoxins expressed in transgenic plants
06/29/2000CA2357413A1 Sensitizing agents for the treatment of skin lesions
06/29/2000CA2357004A1 Expression of immunogenic hepatitis b surface antigens in transgenic plants
06/29/2000CA2356987A1 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
06/29/2000CA2356764A1 Type iii secretion system antigens from bordetella pertussis
06/29/2000CA2356452A1 Compositions and methods for reducing or preventing fertilization in fish and birds
06/29/2000CA2356426A1 Method of using a cyclooxygenase-2 inhibitor and a matrix metalloproteinase inhibitor as a combination therapy in the treatment of neoplasia
06/29/2000CA2356244A1 Somatic cells with ablated prp gene and methods of use
06/29/2000CA2356215A1 Human monoclonal antibodies to ctla-4
06/29/2000CA2355896A1 Antibodies to truncated vegf-d and uses thereof
06/29/2000CA2355876A1 Chlamydia trachomatis antigens
06/29/2000CA2355831A1 Novel fibronectin-binding protein
06/29/2000CA2355680A1 Improved recombinant hepatitis b surface antigen
06/29/2000CA2355364A1 Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
06/29/2000CA2354843A1 Outer surface proteins, their genes, and their use
06/29/2000CA2354135A1 Group b streptococcus proteins, and their use
06/29/2000CA2353960A1 Improvement of tolerance to a xenograft
06/29/2000CA2353848A1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles
06/29/2000CA2353775A1 Compositions and methods for the treatment of tumor
06/29/2000CA2352535A1 Method for preparing suspension of stable posiplexes
06/29/2000CA2352471A1 Compositions and methods for generating monoclonal antibodies representative of a specific cell type
06/29/2000CA2352309A1 Oral vaccine against diarrhea
06/28/2000EP1013772A1 Method for preparing suspension of stable posiplexes
06/28/2000EP1013764A1 Immunomodulators
06/28/2000EP1013757A2 Attenuated forms of bovine viral diarrhea virus
06/28/2000EP1013287A2 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
06/28/2000EP1013285A2 Urokinase-type plasminogen activator receptor
06/28/2000EP1012320A2 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
06/28/2000EP1012309A2 Chimeric polypeptides containing chemokine domains
06/28/2000EP1012308A1 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors
06/28/2000EP1012305A1 Component of bromelain
06/28/2000EP1012304A1 Component of bromelain
06/28/2000EP1012293A2 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
06/28/2000EP1012292A1 Ntn-2 member of tnf ligand family
06/28/2000EP1012287A1 Synthetic polypeptide for diagnosing and treating prion-related diseases
06/28/2000EP1012283A1 Mage-3 peptides presented by hla class ii molecules
06/28/2000EP1012282A1 Cysteine rich receptors-train
06/28/2000EP1012279A1 Mitofusin genes and their uses
06/28/2000EP1012276A2 Recombinant pox virus for immunization against muc1 tumor-associated antigen
06/28/2000EP1012270A2 Kay - a novel immune system protein
06/28/2000EP1012269A2 P13 antigens from borrelia
06/28/2000EP1012262A1 Human frezzled-like protein
06/28/2000EP1012261A1 Secreted proteins and polynucleotides encoding them
06/28/2000EP1012259A2 Tumor targeted vector
06/28/2000EP1012245A1 Surface expression system of hepatitis b virus surface antigen and core antigen of hepatitis c virus by using ice-nucleation protein
06/28/2000EP1012244A1 Rhabdoviruses with reengineered coats
06/28/2000EP1012243A1 Monoclonal antibody 3-6-a specific to surface of dendritic cells among the peripheral blood leukocytes
06/28/2000EP1012242A1 Human sigma receptor
06/28/2000EP1012240A2 Cancer immunotherapy with semi-allogeneic cells
06/28/2000EP1012238A1 Peptides and peptide-loaded antigen presenting cells for the activation of ctl
06/28/2000EP1012236A1 Retrovirus and viral vectors
06/28/2000EP1012232A1 Genetically modified tumor-targeted bacteria with reduced virulence
06/28/2000EP1012230A1 Renibacterium salmoninarum vaccine
06/28/2000EP1012182A2 Chlamydia pneumoniae specific peptides and their use in diagnostic assays
06/28/2000EP1012181A1 Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease
06/28/2000EP1012179A2 Cysteine rich receptors: trail
06/28/2000EP1012176A1 Sperm specific antigens 4.1 and 6.7, dna encoding them and contraceptive vaccines comprising said sperm antigens
06/28/2000EP1012173A1 Isolated nona- and decapeptides which bind to hla molecules, and the use thereof
06/28/2000EP1012171A1 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof
06/28/2000EP1012160A1 Tango-72 and tango-77 nucleic acid molecules and polypeptides
06/28/2000EP1012157A1 $i(BORRELIA BURGDORFERI) POLYNUCLEOTIDES AND SEQUENCES
06/28/2000EP1011725A1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
06/28/2000EP1011724A1 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor
06/28/2000EP1011723A1 88kda tumorigenic growth factor and antagonists
06/28/2000EP1011722A1 Substrates materials with bound cytokine-stimulating polysaccharides or bacterial nucleic acids
06/28/2000EP1011721A1 Vaginal lactobacillus medicant
1 ... 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 ... 1823